Serveur d'exploration Chloroquine - Analysis (France)

Index « Auteurs » - entrée « Xavier Mariette »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Xavier Guillot < Xavier Mariette < Xavier Puéchal  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
000023 (2019) Adrien Mirouse [France] ; Raphaele Séror [France] ; Eric Vicaut [France] ; Xavier Mariette [France] ; Maxime Dougados [France] ; Anne-Laure Fauchais [France] ; Alban Deroux [France] ; Azeddine Dellal [France] ; Nathalie Costedoat-Chalumeau [France] ; Guillaume Denis [France] ; Jeremie Sellam [France] ; Jean-Benoît Arlet [France] ; Christian Lavigne [France] ; Geoffrey Urbanski [France] ; Dominique Fischer-Dumont [France] ; Abdou Diallo [France] ; Olivier Fain [France] ; Arsène Mékinian [France]Arthritis in primary Sjögren's syndrome: Characteristics, outcome and treatment from French multicenter retrospective study
000025 (2019) Kevin L. Winthrop [États-Unis] ; Michael E. Weinblatt [États-Unis] ; Joan Bathon [États-Unis] ; Gerd R. Burmester [Allemagne] ; Philip J. Mease [États-Unis] ; Leslie Crofford [États-Unis] ; Vivian Bykerk [États-Unis] ; Maxime Dougados [France] ; James Todd Rosenbaum [États-Unis] ; Xavier Mariette [France] ; Joachim Sieper [Allemagne] ; Fritz Melchers [Allemagne] ; Bruce N. Cronstein [États-Unis] ; Ferry C. Breedveld [Pays-Bas] ; Joachim Kalden [Allemagne] ; Josef S. Smolen [Autriche] ; Daniel Furst [États-Unis, Italie]Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019
000045 (2019) Jan Leipe [Allemagne] ; Xavier Mariette [France]Management of rheumatic complications of ICI therapy: a rheumatology viewpoint
000047 (2019) Alistair Baber [France] ; Gaetane Nocturne [France] ; Roman Krzysiek [France] ; Julien Henry [France] ; Rakiba Belkhir [France] ; Xavier Mariette [France] ; Raphaele Seror [France]Large granular lymphocyte expansions in primary Sjögren’s syndrome: characteristics and outcomes
000060 (2019) Salam Abbara [France] ; Raphaele Seror [France] ; Julien Henry [France] ; Pascale Chretien [France] ; Aude Gleizes [France] ; Salima Hacein-Bey-Abina [France] ; Xavier Mariette [France] ; Gaetane Nocturne [France]Anti-RNP positivity in primary Sjögren’s syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement
000195 (2013) Jacques-Eric Gottenberg [France] ; Gael Cinquetti [France] ; Claire Larroche [France] ; Bernard Combe [France] ; Eric Hachulla [France] ; Olivier Meyer [France] ; Edouard Pertuiset [France] ; Guy Kaplanski [France] ; Laurent Chiche [France] ; Jean-Marie Berthelot [France] ; Bruno Gombert [France] ; Philippe Goupille [France] ; Christian Marcelli [France] ; Séverine Feuillet [France] ; Jean Leone [France] ; Jean Sibilia [France] ; Charles Zarnitsky [France] ; Philippe Carli [France] ; Stephanie Rist [France] ; Philippe Gaudin [France] ; Carine Salliot [France] ; Muriel Piperno ; Adeline Deplas [France] ; Maxime Breban [France] ; Thierry Lequerre [France] ; Pascal Richette [France] ; Charles Ghiringhelli [France] ; Mohamed Hamidou [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry
000323 (2007) Gerd R. Burmester [Allemagne] ; Xavier Mariette [France] ; Carlomaurizio Montecucco [Italie] ; Indalecio Monteagudo-Sáez [Espagne] ; Michel Malaise [Belgique] ; Athanasios G. Tzioufas [Grèce] ; Johannes W J. Bijlsma [Pays-Bas] ; Kristina Unnebrink [Allemagne] ; Sonja Kary [Allemagne] ; Hartmut Kupper [Allemagne]Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial

List of associated KwdEn.i

Nombre de
documents
Descripteur
1ACR, American College of Rheumatology
1AE, adverse event
1AM, antimalarials
1AZA, azathioprine
1CsA, ciclosporin
1DAS, Disease Activity Score
1DMARD, disease-modifying antirheumatic drug
1DMARDS
1EULAR, European League Against Rheumatism
1HAQ DI, Health Assessment Questionnaire Disability Index
1LEF, leflunomide
1MTX, methotrexate
1PY, patient-year
1Primary Sjögren's syndrome
1RA, rheumatoid arthritis
1Rituximab
1SAE, serious adverse event
1SEER, Surveillance, Epidemiology, and End Results
1SIR, standardised incidence ratio
1SSZ, sulfasalazine
1Synovitis
1TB, tuberculosis
1TNF, tumour necrosis factor
1adalimumab
1antirheumatic agents
1monoclonal antibody
1rheumatoid arthritis
1tumour necrosis factor

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Xavier Mariette" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Xavier Mariette" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Xavier Mariette
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021